Results 221 to 230 of about 63,906 (257)

Acinetobacter Baumannii Nosocomial Infections

Polish Journal of Surgery, 2013
Nosocomial infections caused by strains Acinetobacter baumannii strands are a growing clinical problem. The occurrence of multidrug-resistant strands is observed and that limits the ways of therapy considerably. The aim of the study was to determine the rate of infection and susceptibility spectrum of the species Acinetobacter baumannii isolated from ...
Karol, Sieniawski, Krzysztof, Kaczka, Monika, Rucińska, Ludmiła, Gagis, Lech, Pomorski   +4 more
openaire   +2 more sources

Virulence of Acinetobacter baumannii in proteins moonlighting

Archives of Microbiology, 2021
The diverse function of the moonlighting proteins in Acinetobacter baumannii is highly associated with its virulence that had spurred renewed attention in recent years. The existing and newly formed hypothetical moonlighting proteins, evolve without jeopardizing the structural constraints of their original roles.
A. S. Smiline Girija, Pitchaipillai Sankar Ganesh   +1 more
openaire   +2 more sources

Acinetobacter baumannii and Acinetobacter spp.

2017
Acinetobacter baumannii is a bacterial pathogen increasingly identified in the clinical microbiology laboratory as a cause of infection in humans. Upon microscopic examination, A. baumannii appears as a Gram-negative coccobacillus, and it produces clear colonies when grown on MacConkey agar, indicating its inability to ferment lactose.
Federico Perez, Robert A. Bonomo
openaire   +1 more source

Managing Acinetobacter baumannii infections

Current Opinion in Infectious Diseases, 2019
Purpose of review We reviewed recent data about epidemiology of Acinetobacter baumannii, resistance mechanisms, and therapeutic options for severe infections caused by multidrug-resistant strains. Recent findings A.
Garnacho-Montero, José, Timsit, Jean-François   +1 more
openaire   +3 more sources

The Rise of Carbapenem-Resistant Acinetobacter baumannii

Current Pharmaceutical Design, 2012
Acinetobacter spp. are Gram-negative bacteria that have become one of the most difficult pathogens to treat. The species A. baumannii, largely unknown 30 years ago, has risen to prominence particularly because of its ability to cause infections in immunocompromised patients.
Evans, Benjamin A., Hamouda, Ahmed, Amyes, Sebastian G. B.   +2 more
openaire   +3 more sources

Acinetobacter baumannii: an evolving and cunning opponent

Frontiers in Microbiology
Acinetobacter baumannii is one of the most common multidrug-resistant pathogens causing nosocomial infections. The prevalence of multidrug-resistant A. baumannii infections is increasing because of several factors, including unregulated antibiotic use. A.
Jingchao Shi, Jingchao Shi, Jingchao Shi, Jianghao Cheng, Shourong Liu, Yufeng Zhu, Mingli Zhu   +6 more
exaly   +4 more sources

Genetic Manipulation of Acinetobacter baumannii

Current Protocols in Microbiology, 2014
Abstract Acinetobacter baumannii is a Gram‐negative nosocomial pathogen of clinical importance. A lack of genetic tools has hindered the research of this organism in the past; however, recently, various methods have been designed, modified, and optimized to facilitate the genetic manipulation of A. baumannii.
Anna C, Jacobs, Mitchell G, Thompson, Michael, Gebhardt, Brendan W, Corey, Suleyman, Yildirim, Howard A, Shuman, Daniel V, Zurawski   +6 more
openaire   +2 more sources

Epidemiology of Acinetobacter baumannii of animal origin

International Journal of Antimicrobial Agents, 2011
Acinetobacter baumannii is an opportunistic pathogen responsible for nosocomial infections, however the origins of these bacteria remain unclear. Sixteen A. baumannii strains collected from animals slaughtered for human consumption were investigated for their susceptibility profiles, resistance islands (RIs), class 1 integrons, insertion sequence ...
Hamouda, Ahmed, Findlay, Jacqueline, Al Hassan, Leena, Amyes, Sebastian G B   +3 more
openaire   +3 more sources

Acinetobacter baumannii pseudomeningitis

Heart & Lung, 2002
William M, Gusten, Eric A, Hansen, Burke A, Cunha   +2 more
openaire   +2 more sources

Optimizing Therapy for Acinetobacter baumannii

Seminars in Respiratory and Critical Care Medicine, 2007
Acinetobacter baumannii is a highly resilient, gram-negative coccobacillus that thrives within the unique and complex ecological setting of an intensive care unit. This evolving pathogen has now surpassed human capacity to create new antimicrobials, and has led physicians into a concerning era for hospital-acquired infections.
openaire   +2 more sources